Vaxcyte, Inc.·4

Mar 2, 8:08 PM ET

GUGGENHIME ANDREW 4

Research Summary

AI-generated summary

Updated

Vaxcyte (PCVX) President/CFO Andrew Guggenhime Receives Awards, Surrenders Shares

What Happened

  • Andrew Guggenhime, President and CFO of Vaxcyte (PCVX), received equity awards on February 26, 2026: 44,864 RSU-type awards and 74,993 derivative awards (total 119,857 units) granted at $0.00 per share.
  • To cover tax withholding obligations on vesting, Guggenhime surrendered 898 shares on February 28, 2026 and 1,009 shares on March 2, 2026 at $61.98 per share (proceeds/withholding value $55,658 and $62,538, respectively; total $118,196).
  • These transactions were awards and routine tax-withholding share surrenders — not open-market sales.

Key Details

  • Transaction dates and prices:
    • 2026-02-26: Award of 44,864 shares (RSU) and 74,993 derivative units @ $0.00.
    • 2026-02-28: 898 shares surrendered for tax withholding @ $61.98 (value $55,658).
    • 2026-03-02: 1,009 shares surrendered for tax withholding @ $61.98 (value $62,538).
  • Shares surrendered total: 1,907; withholding value total: $118,196.
  • Shares owned after the reported transactions: not specified in the provided filing.
  • Notable footnotes:
    • F1: The RSUs represent contingent rights to one share each; vesting: 1/4 on Sept 7, 2026, then 1/8 every six months thereafter (service-based).
    • F2: The 898 and 1,009-share disposals are shares surrendered to cover tax withholding upon RSU vesting (cashless withholding).
    • F3: Some shares are held by ALG 2025 GRAT HOLDINGS LLC (a trust entity connected to the reporting person).
    • F4: The 74,993 derivative units vest 1/48 on March 26, 2026 and monthly thereafter (service-based option-style schedule).
  • Filing timeliness: Report filed 2026-03-02 for transactions through 2026-02-26 — appears timely (within the Form 4 two-business-day window).

Context

  • These were compensation awards and routine tax-withholding actions, not market sales or purchases; share-withholding to satisfy taxes is common and does not necessarily indicate insider sentiment.
  • The derivative award follows a monthly vesting schedule (1/48 starting 3/26/2026); RSUs have a later graded vesting schedule (first quarter vests 9/7/2026).